
201 - 500 employees
Founded 2003
💊 Pharmaceuticals
🧬 Biotechnology
Pharmaceuticals • Biotechnology
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing switch-control kinase inhibitors to treat cancer. The company designs targeted small-molecule therapies that address tumor growth and mechanisms of drug resistance, advancing a pipeline that includes ripretinib, vimseltinib (ROMVIMZA™), tirabrutinib and several other candidates; ROMVIMZA received European Commission approval for tenosynovial giant cell tumor. Deciphera emphasizes patient-focused oncology research and, as of June 2024, is a member of ONO Pharma.
🔥 22 minutes ago
Medical Science Liaison II serving as a field-based scientific expert within oncology. Building relationships with KOLs and delivering scientific insights while ensuring compliance and strategic alignment.